Shell Option Alert: Apr 17 $70 Calls Sweep (46) near the Bid: 1488 vs 19023 OI; Earnings 5/2 Before Open 

Shell Option Alert: Apr 17 $70 Calls Sweep (46) near the Bid: 1488 @ $3.401 vs 19023 OI; Earnings 5/2 Before Open Ref=$72.9

Shell Option Alert: Jan 16 $75 Calls at the Bid: 2000 vs 2706 OI; Earnings 5/2 Before Open 

Shell Option Alert: Jan 16 $75 Calls at the Bid: 2000 @ $4.2 vs 2706 OI; Earnings 5/2 Before Open Ref=$73.52

Shell (NYSE:SHEL) Bolsa

Shell

Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2023, it produced 1.5 million barrels of liquids and 7.3 billion cubic feet of natural gas per day. At end-2023, reserves stood at 9.6 billion barrels of oil equivalent, 49% of which, consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.6 mmb/d located in the Americas, Asia, Africa, and Europe and sells about 12 million tons per year of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.

Equities

News

Guidance

Movers

General

EQNR

SHEL

Shell ajusta a la baja sus previsiones de producción de gas y GNL para el cuarto trimestre, provocando una caída del 3% en sus acciones.

Shell reduce pronóstico de producción en 4T24: Acciones caen un 3%

Large Cap

Contracts

Media

Market Vectors RVE Hard Assets Producers ETF

PWER

Shell firma un acuerdo de GNL con BOTAŞ, diversificando el suministro energético de Turquía. Acciones de SHEL caen antes de la apertura.

¿Qué está pasando con las acciones de Shell (SHEL) antes de la apertura del martes?

First Trust Exchange-Traded Fund IV FT Energy Income Partners Strategy ETF

EIPX

HJEN

BP no cree que Venture Global LNG necesite más tiempo para iniciar la producción comercial en su planta Calcasieu Pass.

¿Qué está pasando con las acciones de BP en el premercado del jueves?

Shell PLC American Depositary Shares (each representing two (2) Ordinary Shares)

Shell PLC

SHELF DRILLING LTD by Shelf Drilling Ltd.

Shelf Drilling Ltd

<p><strong>Vulcan Materials</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMC#NYSE">VMC</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-04-30. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Vulcan Materials will report an <strong>earnings per share</strong> (EPS) of $0.78. </p>
<p>Vulcan Materials bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Historical Earnings Performance</h3>
<p>The company's EPS beat by $0.42 in the last quarter, leading to a 2.86% drop in the share price on the following day.</p>
<p>Here's a look at Vulcan Materials's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.75</td>
<td>2.32</td>
<td>2.61</td>
<td>0.74</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.17</td>
<td>2.22</td>
<td>2.35</td>
<td>0.80</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-3.0%</td>
<td>-1.0%</td>
<td>-2.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935339_0.png" alt="eps graph" /></p>
<h3>Performance of Vulcan Materials Shares</h3>
<p>Shares of Vulcan Materials were trading at $245.39 as of April 28. Over the last 52-week period, shares are down 5.34%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/VMC/earnings"><strong>To track all earnings releases for Vulcan Materials visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

A Preview Of Vulcan Materials's Earnings

<p>Deep-pocketed investors have adopted a bullish approach towards United Parcel Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in UPS usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for United Parcel Service. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 50% leaning bullish and 40% bearish. Among these notable options, 2 are puts, totaling $83,800, and 8 are calls, amounting to $287,457.</p>
<h3>Predicted Price Range</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $95.0 and $105.0 for United Parcel Service, spanning the last three months.</p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for United Parcel Service options trades today is 910.5 with a total volume of 4,173.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for United Parcel Service's big money trades within a strike price range of $95.0 to $105.0 over the last 30 days.</p>
<h3>United Parcel Service Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935331_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>UPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$6.15</td>
<td>$5.6</td>
<td>$5.65</td>
<td>$95.00</td>
<td>$52.8K</td>
<td align="right">598</td>
<td align="right">110</td>
</tr>
<tr>
<td>UPS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/02/25</td>
<td>$2.95</td>
<td>$2.35</td>
<td>$2.34</td>
<td>$99.00</td>
<td>$46.8K</td>
<td align="right">537</td>
<td align="right">245</td>
</tr>
<tr>
<td>UPS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/30/25</td>
<td>$3.7</td>
<td>$2.45</td>
<td>$3.7</td>
<td>$98.00</td>
<td>$37.0K</td>
<td align="right">113</td>
<td align="right">100</td>
</tr>
<tr>
<td>UPS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$16.5</td>
<td>$13.9</td>
<td>$13.9</td>
<td>$95.00</td>
<td>$34.7K</td>
<td align="right">278</td>
<td align="right">28</td>
</tr>
<tr>
<td>UPS</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$16.1</td>
<td>$13.55</td>
<td>$15.0</td>
<td>$95.00</td>
<td>$34.5K</td>
<td align="right">278</td>
<td align="right">28</td>
</tr>
</tbody>
</table>
</p>
<h3>About United Parcel Service</h3>
<p>As the world's largest parcel delivery company, UPS manages a massive fleet of more than 500 planes and 100,000 vehicles, along with many hundreds of sorting facilities, to deliver an average of about 22 million packages per day to residences and businesses across the globe. UPS' domestic US package operations generate around 65% of total revenue while international package makes up 20%. Air and ocean freight forwarding and contract logistics make up the remainder.</p>
<p>Having examined the options trading patterns of United Parcel Service, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>United Parcel Service's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 1,396,769, the UPS's price is up by 0.09%, now at $97.17. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 0 days.</li>
</ul>
<h3>What Analysts Are Saying About United Parcel Service</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $120.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Buy rating for United Parcel Service, targeting a price of $127.<br />
&#x2A; An analyst from Raymond James has decided to maintain their Strong Buy rating on United Parcel Service, which currently sits at a price target of $130.<br />
&#x2A; An analyst from Truist Securities has decided to maintain their Buy rating on United Parcel Service, which currently sits at a price target of $130.<br />
&#x2A; An analyst from Citigroup persists with their Buy rating on United Parcel Service, maintaining a target price of $123.<br />
&#x2A; An analyst from Barclays persists with their Underweight rating on United Parcel Service, maintaining a target price of $90. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest United Parcel Service options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


Options

Markets

What the Options Market Tells Us About United Parcel Service

<p>Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) is preparing to release its quarterly earnings on Wednesday, 2025-04-30. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Microsoft to report an <strong>earnings per share</strong> (EPS) of $3.22.</p>
<p>Investors in Microsoft are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Performance in Previous Earnings</h3>
<p>In the previous earnings release, the company beat EPS by $0.13, leading to a 6.18% drop in the share price the following trading session.</p>
<p>Here's a look at Microsoft's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>3.10</td>
<td>3.1</td>
<td>2.93</td>
<td>2.82</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>3.23</td>
<td>3.3</td>
<td>2.95</td>
<td>2.94</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-6.0%</td>
<td>-6.0%</td>
<td>-1.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935327_0_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Microsoft were trading at $391.16 as of April 28. Over the last 52-week period, shares are down 0.58%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<h3>Analyst Opinions on Microsoft</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Microsoft.</p>
<p>Analysts have provided Microsoft with 21 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $486.14, suggesting a potential 24.28% upside.</p>
<h3>Comparing Ratings with Competitors</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of Oracle, ServiceNow and Palo Alto Networks, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Oracle, with an average 1-year price target of $177.13, suggesting a potential 54.72% downside.</li>
<li>Analysts currently favor an Outperform trajectory for ServiceNow, with an average 1-year price target of $1074.27, suggesting a potential 174.64% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Palo Alto Networks, with an average 1-year price target of $214.26, suggesting a potential 45.22% downside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for Oracle, ServiceNow and Palo Alto Networks, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Microsoft</td>
<td>Outperform</td>
<td>12.27%</td>
<td>$47.83B</td>
<td>8.17%</td>
</tr>
<tr>
<td>Oracle</td>
<td>Neutral</td>
<td>6.40%</td>
<td>$9.94B</td>
<td>19.27%</td>
</tr>
<tr>
<td>ServiceNow</td>
<td>Outperform</td>
<td>18.63%</td>
<td>$2.44B</td>
<td>4.66%</td>
</tr>
<tr>
<td>Palo Alto Networks</td>
<td>Outperform</td>
<td>14.29%</td>
<td>$1.66B</td>
<td>4.35%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Microsoft ranks at the top for Gross Profit and Return on Equity among its peers. It ranks in the middle for Revenue Growth.</p>
<h3>Delving into Microsoft's Background</h3>
<p>Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).</p>
<h3>Microsoft: A Financial Overview</h3>
<p><strong>Market Capitalization:</strong> Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Microsoft showcased positive performance, achieving a revenue growth rate of <strong>12.27%</strong> as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> Microsoft's net margin is impressive, surpassing industry averages. With a net margin of <strong>34.62%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Microsoft's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>8.17%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Microsoft's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>4.56%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.21</strong>.</p>
<p><a href="https://www.benzinga.com/quote/MSFT/earnings"><strong>To track all earnings releases for Microsoft visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


MSFT

What's Next: Microsoft's Earnings Preview

<p>Financial giants have made a conspicuous bullish move on Costco Wholesale. Our analysis of options history for Costco Wholesale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) revealed 13 unusual trades.</p>
<p>Delving into the details, we found 69% of traders were bullish, while 15% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $309,600, and 8 were calls, valued at $349,875.</p>
<h3>What's The Price Target?</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $700.0 to $1000.0 for Costco Wholesale during the past quarter. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Costco Wholesale stands at 335.11, with a total volume reaching 187.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Costco Wholesale, situated within the strike price corridor from $700.0 to $1000.0, throughout the last 30 days.</p>
<h3>Costco Wholesale 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935327_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>COST</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$73.5</td>
<td>$70.3</td>
<td>$70.3</td>
<td>$1000.00</td>
<td>$70.3K</td>
<td align="right">316</td>
<td align="right">0</td>
</tr>
<tr>
<td>COST</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$71.35</td>
<td>$69.0</td>
<td>$69.0</td>
<td>$1000.00</td>
<td>$69.0K</td>
<td align="right">316</td>
<td align="right">20</td>
</tr>
<tr>
<td>COST</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$70.45</td>
<td>$68.8</td>
<td>$68.8</td>
<td>$1000.00</td>
<td>$68.8K</td>
<td align="right">316</td>
<td align="right">30</td>
</tr>
<tr>
<td>COST</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$68.95</td>
<td>$68.2</td>
<td>$68.2</td>
<td>$1000.00</td>
<td>$68.2K</td>
<td align="right">316</td>
<td align="right">30</td>
</tr>
<tr>
<td>COST</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$77.6</td>
<td>$73.3</td>
<td>$77.6</td>
<td>$925.00</td>
<td>$62.0K</td>
<td align="right">260</td>
<td align="right">8</td>
</tr>
</tbody>
</table>
</p>
<h3>About Costco Wholesale</h3>
<p>Costco operates a membership-based, no-frills retail model predicated on offering a select product assortment in bulk quantities at bargain prices. The firm avoids maintaining costly product displays by keeping inventory on pallets and limits distribution expenses by storing its inventory at point of sale in the warehouse. Given its frugal cost structure, the firm is able to price its merchandise below that of competing retailers, driving high sales volume per warehouse and generating strong profits on thin margins. Costco operates over 600 warehouses in the United States and has over 60% share in the domestic warehouse club industry. Internationally, Costco operates another 280 warehouses, primarily in Canada, Mexico, Japan, and the UK.</p>
<p>In light of the recent options history for Costco Wholesale, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Costco Wholesale's Current Market Status</h3>
<ul>
<li>Trading volume stands at 112,665, with COST's price down by -0.06%, positioned at $977.99.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 30 days.</li>
</ul>
<h3>What Analysts Are Saying About Costco Wholesale</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $1064.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; In a cautious move, an analyst from Mizuho downgraded its rating to Neutral, setting a price target of $975.<br />
&#x2A; Consistent in their evaluation, an analyst from Telsey Advisory Group keeps a Outperform rating on Costco Wholesale with a target price of $1100.<br />
&#x2A; Consistent in their evaluation, an analyst from Telsey Advisory Group keeps a Outperform rating on Costco Wholesale with a target price of $1100.<br />
&#x2A; An analyst from Telsey Advisory Group persists with their Outperform rating on Costco Wholesale, maintaining a target price of $1100.<br />
&#x2A; Maintaining their stance, an analyst from Loop Capital continues to hold a Buy rating for Costco Wholesale, targeting a price of $1045. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Costco Wholesale with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


COST

Costco Wholesale Unusual Options Activity For April 29

<p>Atmos Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATO#NYSE">ATO</a>) has outperformed the market over the past 10 years by 1.5% on an annualized basis producing an average annual return of 11.67%. Currently, Atmos Energy has a market capitalization of $25.13 billion. </p>
<p><strong>Buying $1000 In ATO:</strong> If an investor had bought $1000 of ATO stock 10 years ago, it would be worth <strong>$2,917.45</strong> today based on a price of $158.33 for ATO at the time of writing.</p>
<h3>Atmos Energy's Performance Over Last 10 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935322_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Trading Ideas

Here's How Much $1000 Invested In Atmos Energy 10 Years Ago Would Be Worth Today

<p>Financial giants have made a conspicuous bullish move on Spotify Technology. Our analysis of options history for Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) revealed 42 unusual trades.</p>
<p>Delving into the details, we found 47% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 18 were puts, with a value of $1,007,907, and 24 were calls, valued at $1,596,947.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $260.0 to $690.0 for Spotify Technology over the recent three months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Spotify Technology options trades today is 459.77 with a total volume of 7,296.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Spotify Technology's big money trades within a strike price range of $260.0 to $690.0 over the last 30 days.</p>
<h3>Spotify Technology Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935321_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/02/25</td>
<td>$25.0</td>
<td>$24.95</td>
<td>$25.0</td>
<td>$540.00</td>
<td>$347.5K</td>
<td align="right">24</td>
<td align="right">300</td>
</tr>
<tr>
<td>SPOT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$132.2</td>
<td>$130.05</td>
<td>$132.2</td>
<td>$690.00</td>
<td>$171.8K</td>
<td align="right">2</td>
<td align="right">14</td>
</tr>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/02/25</td>
<td>$60.0</td>
<td>$53.0</td>
<td>$53.0</td>
<td>$500.00</td>
<td>$159.0K</td>
<td align="right">88</td>
<td align="right">30</td>
</tr>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/02/25</td>
<td>$25.0</td>
<td>$24.95</td>
<td>$25.0</td>
<td>$540.00</td>
<td>$107.5K</td>
<td align="right">24</td>
<td align="right">0</td>
</tr>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/02/25</td>
<td>$25.0</td>
<td>$24.95</td>
<td>$25.0</td>
<td>$540.00</td>
<td>$105.0K</td>
<td align="right">24</td>
<td align="right">130</td>
</tr>
</tbody>
</table>
</p>
<h3>About Spotify Technology</h3>
<p>Spotify is the leading global music streaming service provider, with nearly 700 million monthly active users and over 250 million paying subscribers, with the latter comprising the firm's premium segment. most of the firm's revenue and nearly all its gross profit come from the subscribers, who pay a monthly fee to access a very comprehensive music library that consists of most of the most popular songs ever recorded, including all from the major record labels. The firm also sells separate audiobook subscriptions and integrates podcasts within its standard music app. Podcast content is not exclusive and is typically free to access on other platforms. Ad-supported users can access a similar music catalog but cannot customize a similar on-demand experience.</p>
<h3>Present Market Standing of Spotify Technology</h3>
<ul>
<li>With a trading volume of 1,737,979, the price of SPOT is down by -6.41%, reaching $559.4.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 0 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Spotify Technology</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $654.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Wolfe Research has elevated its stance to Outperform, setting a new price target at $660.<br />
&#x2A; Maintaining their stance, an analyst from Keybanc continues to hold a Overweight rating for Spotify Technology, targeting a price of $625.<br />
&#x2A; An analyst from Macquarie persists with their Outperform rating on Spotify Technology, maintaining a target price of $665.<br />
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Buy rating for Spotify Technology, targeting a price of $680.<br />
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on Spotify Technology, which currently sits at a price target of $640. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Spotify Technology with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


SPOT

Decoding Spotify Technology's Options Activity: What's the Big Picture?

<p><strong>Meta Platforms</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-04-30. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Meta Platforms will report an <strong>earnings per share</strong> (EPS) of $5.22. </p>
<p>Anticipation surrounds Meta Platforms's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Past Earnings Performance</h3>
<p>During the last quarter, the company reported an EPS beat by $1.26, leading to a 1.55% increase in the share price on the subsequent day.</p>
<p>Here's a look at Meta Platforms's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>6.76</td>
<td>5.25</td>
<td>4.71</td>
<td>4.32</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>8.02</td>
<td>6.03</td>
<td>5.16</td>
<td>4.71</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>2.0%</td>
<td>-4.0%</td>
<td>5.0%</td>
<td>-11.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935315_0.png" alt="eps graph" /></p>
<h3>Meta Platforms Share Price Analysis</h3>
<p>Shares of Meta Platforms were trading at $549.74 as of April 28. Over the last 52-week period, shares are up 25.04%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Observations about Meta Platforms</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Meta Platforms.</p>
<p>A total of 47 analyst ratings have been received for Meta Platforms, with the consensus rating being Buy. The average one-year price target stands at $720.28, suggesting a potential 31.02% upside.</p>
<h3>Understanding Analyst Ratings Among Peers</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of Alphabet, Reddit and Pinterest, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Alphabet, with an average 1-year price target of $195.39, suggesting a potential 64.46% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Reddit, with an average 1-year price target of $177.19, suggesting a potential 67.77% downside.</li>
<li>Analysts currently favor an Buy trajectory for Pinterest, with an average 1-year price target of $42.18, suggesting a potential 92.33% downside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
<p>Within the peer analysis summary, vital metrics for Alphabet, Reddit and Pinterest are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Meta Platforms</td>
<td>Buy</td>
<td>20.63%</td>
<td>$39.55B</td>
<td>12.00%</td>
</tr>
<tr>
<td>Alphabet</td>
<td>Outperform</td>
<td>12.04%</td>
<td>$53.87B</td>
<td>10.30%</td>
</tr>
<tr>
<td>Reddit</td>
<td>Outperform</td>
<td>71.25%</td>
<td>$395.86M</td>
<td>3.46%</td>
</tr>
<tr>
<td>Pinterest</td>
<td>Buy</td>
<td>17.62%</td>
<td>$957.17M</td>
<td>48.33%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Meta Platforms is positioned at the top for Revenue Growth and Gross Profit among its peers. However, it ranks at the bottom for Return on Equity.</p>
<h3>About Meta Platforms</h3>
<p>Meta is the largest social media company in the world, boasting close to 4 billion monthly active users worldwide. The firm's "Family of Apps," its core business, consists of Facebook, Instagram, Messenger, and WhatsApp. End users can leverage these applications for a variety of different purposes, from keeping in touch with friends to following celebrities and running digital businesses for free. Meta packages customer data, gleaned from its application ecosystem and sells ads to digital advertisers. While the firm has been investing heavily in its Reality Labs business, it remains a very small part of Meta's overall sales.</p>
<h3>Meta Platforms's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Meta Platforms's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>20.63%</strong> as of 31 December, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Communication Services sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>43.07%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>12.0%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Meta Platforms's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>7.83%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Meta Platforms's debt-to-equity ratio is below the industry average at <strong>0.27</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<p><a href="https://www.benzinga.com/quote/META/earnings"><strong>To track all earnings releases for Meta Platforms visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


What to Expect from Meta Platforms's Earnings

<p><strong>Illinois Tool Works</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITW#NYSE">ITW</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-04-30. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Illinois Tool Works will report an <strong>earnings per share</strong> (EPS) of $2.35. </p>
<p>The market awaits Illinois Tool Works's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Performance in Previous Earnings</h3>
<p>Last quarter the company beat EPS by $0.05, which was followed by a 0.33% increase in the share price the next day.</p>
<p>Here's a look at Illinois Tool Works's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.49</td>
<td>2.53</td>
<td>2.49</td>
<td>2.36</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.54</td>
<td>2.65</td>
<td>2.54</td>
<td>2.44</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>0.0%</td>
<td>-1.0%</td>
<td>-1.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935302_0.png" alt="eps graph" /></p>
<h3>Tracking Illinois Tool Works's Stock Performance</h3>
<p>Shares of Illinois Tool Works were trading at $240.12 as of April 28. Over the last 52-week period, shares are down 0.48%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analyst Observations about Illinois Tool Works</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Illinois Tool Works.</p>
<p>The consensus rating for Illinois Tool Works is Neutral, based on 11 analyst ratings. With an average one-year price target of $252.64, there's a potential 5.21% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of Parker Hannifin, Ingersoll Rand and Xylem, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Parker Hannifin, with an average 1-year price target of $735.15, suggesting a potential 206.16% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Ingersoll Rand, with an average 1-year price target of $93.0, suggesting a potential 61.27% downside.</li>
<li>Analysts currently favor an Buy trajectory for Xylem, with an average 1-year price target of $140.67, suggesting a potential 41.42% downside.</li>
</ul>
<h3>Insights: Peer Analysis</h3>
<p>In the peer analysis summary, key metrics for Parker Hannifin, Ingersoll Rand and Xylem are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Illinois Tool Works</td>
<td>Neutral</td>
<td>-1.28%</td>
<td>$1.71B</td>
<td>22.36%</td>
</tr>
<tr>
<td>Parker Hannifin</td>
<td>Outperform</td>
<td>-1.63%</td>
<td>$1.72B</td>
<td>7.29%</td>
</tr>
<tr>
<td>Ingersoll Rand</td>
<td>Outperform</td>
<td>4.24%</td>
<td>$815.40M</td>
<td>2.25%</td>
</tr>
<tr>
<td>Xylem</td>
<td>Buy</td>
<td>6.52%</td>
<td>$857M</td>
<td>3.07%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Illinois Tool Works ranks at the top for Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.</p>
<h3>All You Need to Know About Illinois Tool Works</h3>
<p>Founded in 1912, Illinois Tool Works has become a diversified industrial manufacturer through acquisitions and innovations that follow customer needs. ITW operates through seven business segments, with no segment representing more than one fifth of revenue. ITW's automotive OEM segment sells vehicle components; its food equipment segment sells commercial kitchen appliances; its test &amp; measurement and electronics segment sells inspection and analysis equipment; its welding segment sells welding equipment and consumables; its polymers &amp; fluids segment sells industrial and consumer adhesives, solvents, and coatings; its construction products segment sells building fasteners and tools; and its specialty products segment sells medical, packaging, HVAC, and airport ground equipment.</p>
<h3>Illinois Tool Works: Financial Performance Dissected</h3>
<p><strong>Market Capitalization Analysis:</strong> With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Illinois Tool Works's financials over 3 months reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately <strong>-1.28%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.</p>
<p><strong>Net Margin:</strong> Illinois Tool Works's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>19.07%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Illinois Tool Works's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>22.36%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Illinois Tool Works's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>4.86%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Illinois Tool Works's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>2.44</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<p><a href="https://www.benzinga.com/quote/ITW/earnings"><strong>To track all earnings releases for Illinois Tool Works visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Outlook For Illinois Tool Works

<p><strong>Trane Technologies</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TT#NYSE">TT</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-04-30. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Trane Technologies will report an <strong>earnings per share</strong> (EPS) of $2.20. </p>
<p>Investors in Trane Technologies are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Past Earnings Performance</h3>
<p>During the last quarter, the company reported an EPS beat by $0.07, leading to a 0.97% drop in the share price on the subsequent day.</p>
<p>Here's a look at Trane Technologies's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.54</td>
<td>3.24</td>
<td>3.08</td>
<td>1.64</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.61</td>
<td>3.37</td>
<td>3.30</td>
<td>1.94</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-1.0%</td>
<td>-1.0%</td>
<td>-0.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935290_0.png" alt="eps graph" /></p>
<h3>Trane Technologies Share Price Analysis</h3>
<p>Shares of Trane Technologies were trading at $351.32 as of April 28. Over the last 52-week period, shares are up 11.32%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Views on Trane Technologies</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Trane Technologies.</p>
<p>Analysts have given Trane Technologies a total of 7 ratings, with the consensus rating being Buy. The average one-year price target is $407.71, indicating a potential 16.05% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of Johnson Controls Intl, Carrier Global and Lennox Intl, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Johnson Controls Intl, with an average 1-year price target of $93.75, suggesting a potential 73.31% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Carrier Global, with an average 1-year price target of $76.25, suggesting a potential 78.3% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Lennox Intl, with an average 1-year price target of $598.71, suggesting a potential 70.42% upside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
<p>Within the peer analysis summary, vital metrics for Johnson Controls Intl, Carrier Global and Lennox Intl are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Trane Technologies</td>
<td>Buy</td>
<td>10.17%</td>
<td>$1.71B</td>
<td>8.03%</td>
</tr>
<tr>
<td>Johnson Controls Intl</td>
<td>Outperform</td>
<td>4.17%</td>
<td>$1.93B</td>
<td>2.62%</td>
</tr>
<tr>
<td>Carrier Global</td>
<td>Outperform</td>
<td>19.28%</td>
<td>$1.34B</td>
<td>17.73%</td>
</tr>
<tr>
<td>Lennox Intl</td>
<td>Neutral</td>
<td>2.44%</td>
<td>$328.50M</td>
<td>14.13%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Trane Technologies ranks first in revenue growth among its peers. It ranks second in gross profit and return on equity.</p>
<h3>All You Need to Know About Trane Technologies</h3>
<p>Trane Technologies manufactures and services commercial and residential HVAC systems and transportation refrigeration solutions under its prominent Trane, American Standard, and Thermo King brands. The $20 billion company generates approximately 70% of sales from equipment and 30% from parts and services. While the firm is domiciled in Ireland, North America accounts for over 80% of its revenue.</p>
<h3>Breaking Down Trane Technologies's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Trane Technologies's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>10.17%</strong> as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>12.4%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Trane Technologies's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>8.03%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Trane Technologies's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>2.94%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.64</strong>.</p>
<p><a href="https://www.benzinga.com/quote/TT/earnings"><strong>To track all earnings releases for Trane Technologies visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Uncovering Potential: Trane Technologies's Earnings Preview

<p>Wells Fargo  analyst Stan Berenshteyn   maintains GoodRx Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDRX#NASDAQ">GDRX</a>) with a Overweight and lowers the price target from $8 to $7.</p>


Price Target

Analyst Ratings

GDRX

Wells Fargo Maintains Overweight on GoodRx Holdings, Lowers Price Target to $7

<p>In the preceding three months, 6 analysts have released ratings for Safehold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAFE#NYSE">SAFE</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $23.67, with a high estimate of $35.00 and a low estimate of $17.00. This current average has decreased by 7.79% from the previous average price target of $25.67. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935267_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>A clear picture of Safehold's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<p>&#x7C;      Analyst       &#x7C;    Analyst Firm    &#x7C; Action Taken  &#x7C;     Rating      &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C;<br />
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;-----------------&#x7C;--------------------&#x7C;--------------------&#x7C;<br />
&#x7C;Richard Hill        &#x7C;Morgan Stanley      &#x7C;Lowers         &#x7C;Equal-Weight     &#x7C;              $17.00&#x7C;$19.00              &#x7C;<br />
&#x7C;Haendel St. Juste   &#x7C;Mizuho              &#x7C;Lowers         &#x7C;Neutral          &#x7C;              $19.00&#x7C;$25.00              &#x7C;<br />
&#x7C;Richard Anderson    &#x7C;Wedbush             &#x7C;Maintains      &#x7C;Neutral          &#x7C;              $20.00&#x7C;$20.00              &#x7C;<br />
&#x7C;Mitch Germain       &#x7C;JMP Securities      &#x7C;Lowers         &#x7C;Market Outperform&#x7C;              $32.00&#x7C;$35.00              &#x7C;<br />
&#x7C;Richard Anderson    &#x7C;Wedbush             &#x7C;Lowers         &#x7C;Neutral          &#x7C;              $19.00&#x7C;$20.00              &#x7C;<br />
&#x7C;Mitch Germain       &#x7C;JMP Securities      &#x7C;Maintains      &#x7C;Market Outperform&#x7C;              $35.00&#x7C;$35.00              &#x7C;</p>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Safehold. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Safehold compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Safehold's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Safehold's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/SAFE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Safehold analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.</p>
<h2>About Safehold</h2>
<p>Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.</p>
<h3>Financial Milestones: Safehold's Journey</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Decline in Revenue:</strong> Over the 3M period, Safehold faced challenges, resulting in a decline of approximately <strong>-10.83%</strong> in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Safehold's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>28.34%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Safehold's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>1.12%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>0.38%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>1.8</strong>.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


SAFE

6 Analysts Assess Safehold: What You Need To Know

<p>Allstate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>) will release its quarterly earnings report on Wednesday, 2025-04-30. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Allstate to report an <strong>earnings per share</strong> (EPS) of $3.76.</p>
<p>Investors in Allstate are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Past Earnings Performance</h3>
<p>Last quarter the company beat EPS by $1.39, which was followed by a 0.59% drop in the share price the next day.</p>
<p>Here's a look at Allstate's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>6.28</td>
<td>2.47</td>
<td>0.37</td>
<td>3.94</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>7.67</td>
<td>3.91</td>
<td>1.61</td>
<td>5.13</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-1.0%</td>
<td>-2.0%</td>
<td>4.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935267_0_0.png" alt="eps graph" /></p>
<h3>Tracking Allstate's Stock Performance</h3>
<p>Shares of Allstate were trading at $195.41 as of April 28. Over the last 52-week period, shares are up 13.63%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/ALL/earnings"><strong>To track all earnings releases for Allstate visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


A Peek at Allstate's Future Earnings

<p>Roper Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROP#NASDAQ">ROP</a>) has been analyzed by 8 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $624.5, a high estimate of $685.00, and a low estimate of $465.00. This current average reflects an increase of 0.33% from the previous average price target of $622.43. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935258_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>A comprehensive examination of how financial experts perceive Roper Technologies is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<p>&#x7C;      Analyst       &#x7C;    Analyst Firm    &#x7C; Action Taken  &#x7C;    Rating     &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C;<br />
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C;<br />
&#x7C;Brad Reback         &#x7C;Stifel              &#x7C;Lowers         &#x7C;Buy            &#x7C;             $650.00&#x7C;$685.00             &#x7C;<br />
&#x7C;Joe Vruwink         &#x7C;Baird               &#x7C;Raises         &#x7C;Outperform     &#x7C;             $668.00&#x7C;$660.00             &#x7C;<br />
&#x7C;Stephen Tusa        &#x7C;JP Morgan           &#x7C;Lowers         &#x7C;Neutral        &#x7C;             $465.00&#x7C;$558.00             &#x7C;<br />
&#x7C;Brad Reback         &#x7C;Stifel              &#x7C;Announces      &#x7C;Buy            &#x7C;             $685.00&#x7C;-                   &#x7C;<br />
&#x7C;Christopher Glynn   &#x7C;Oppenheimer         &#x7C;Raises         &#x7C;Outperform     &#x7C;             $640.00&#x7C;$630.00             &#x7C;<br />
&#x7C;Brian Gesuale       &#x7C;Raymond James       &#x7C;Raises         &#x7C;Strong Buy     &#x7C;             $655.00&#x7C;$620.00             &#x7C;<br />
&#x7C;Terry Tillman       &#x7C;Truist Securities   &#x7C;Raises         &#x7C;Buy            &#x7C;             $675.00&#x7C;$665.00             &#x7C;<br />
&#x7C;Stephen Tusa        &#x7C;JP Morgan           &#x7C;Raises         &#x7C;Neutral        &#x7C;             $558.00&#x7C;$539.00             &#x7C;</p>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Roper Technologies. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Roper Technologies compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Roper Technologies's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Roper Technologies's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/ROP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Roper Technologies analyst ratings.</strong></a></p>
<h2>All You Need to Know About Roper Technologies</h2>
<p>Roper Technologies is a diversified technology company that operates three segments: application software, network software, and technology enabled products. Roper acquires asset light, cash generative businesses and deploys excess cash to acquire further portfolio companies. The firm operates a highly decentralized model with portfolio company management holding autonomy and accountability for key operational decisions, and a small, centralized team overseeing capital deployment and providing executive coaching and reviewing strategic goals.</p>
<h3>Understanding the Numbers: Roper Technologies's Finances</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Roper Technologies's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately <strong>16.34%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> Roper Technologies's net margin is impressive, surpassing industry averages. With a net margin of <strong>24.63%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Roper Technologies's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>2.47%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Roper Technologies's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>1.47%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.41</strong>, Roper Technologies adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Assessing Roper Technologies: Insights From 8 Financial Analysts

Macro Economic Events

Econ #s

Economics

JOLTS Job Openings For March 7.192M Vs 7.490M Est.; 7.480M Prior

<p>Ratings for Sutro Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRO#NASDAQ">STRO</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for Sutro Biopharma, revealing an average target of $1.75, a high estimate of $2.00, and a low estimate of $1.00. This current average has decreased by 78.79% from the previous average price target of $8.25. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935247_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>The perception of Sutro Biopharma by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<p>&#x7C;      Analyst       &#x7C;    Analyst Firm    &#x7C; Action Taken  &#x7C;    Rating     &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C;<br />
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C;<br />
&#x7C;Andres Maldonado    &#x7C;HC Wainwright &amp; Co. &#x7C;Maintains      &#x7C;Neutral        &#x7C;               $2.00&#x7C;$2.00               &#x7C;<br />
&#x7C;Andrew Fein         &#x7C;HC Wainwright &amp; Co. &#x7C;Lowers         &#x7C;Neutral        &#x7C;               $2.00&#x7C;$12.00              &#x7C;<br />
&#x7C;David Nierengarten  &#x7C;Wedbush             &#x7C;Lowers         &#x7C;Neutral        &#x7C;               $2.00&#x7C;$8.00               &#x7C;<br />
&#x7C;Tazeen Ahmad        &#x7C;B of A Securities   &#x7C;Lowers         &#x7C;Underperform   &#x7C;               $1.00&#x7C;$11.00              &#x7C;</p>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Sutro Biopharma. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Sutro Biopharma compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Sutro Biopharma's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>To gain a panoramic view of Sutro Biopharma's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/STRO/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Sutro Biopharma analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.</p>
<h2>About Sutro Biopharma</h2>
<p>Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.</p>
<h3>Key Indicators: Sutro Biopharma's Financial Health</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Revenue Challenges:</strong> Sutro Biopharma's revenue growth over 3M faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately <strong>-86.98%</strong>. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>-489.18%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>-92.98%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>-17.27%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Sutro Biopharma's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>0.52</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


STRO

Demystifying Sutro Biopharma: Insights From 4 Analyst Reviews

<p>In the current session, <strong>Nucor Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>)</strong> is trading at $114.38, after a <strong>1.88%</strong> decrease. Over the past month, the stock decreased by <strong>4.42%</strong>, and in the past year, by <strong>32.19%</strong>. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2025/1745935236_0.png" alt="Past Year Chart" /></p>

<h3>Comparing Nucor P/E Against Its Peers</h3>
<p>The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. </p>
<p>Compared to the aggregate P/E ratio of the <strong>47.68</strong> in the Metals &amp; Mining industry, Nucor Inc. has a lower P/E ratio of <strong>13.78</strong>. Shareholders might be inclined to think that  the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2025/1745935236_1.png" alt="Guage" /></p>

<p>In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions. </p>


Intraday Update

P/E Ratio Insights for Nucor

<p>Ratings for Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) were provided by 17 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">7</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for Eastman Chemical, presenting an average target of $104.59, a high estimate of $128.00, and a low estimate of $76.00. A 8.21% drop is evident in the current average compared to the previous average price target of $113.94. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935235_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Eastman Chemical. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<p>&#x7C;      Analyst       &#x7C;    Analyst Firm    &#x7C; Action Taken  &#x7C;    Rating     &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C;<br />
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C;<br />
&#x7C;Michael Leithead    &#x7C;Barclays            &#x7C;Lowers         &#x7C;Equal-Weight   &#x7C;              $85.00&#x7C;$108.00             &#x7C;<br />
&#x7C;Duffy Fischer       &#x7C;Goldman Sachs       &#x7C;Lowers         &#x7C;Neutral        &#x7C;              $87.00&#x7C;$112.00             &#x7C;<br />
&#x7C;Aleksey Yefremov    &#x7C;Keybanc             &#x7C;Lowers         &#x7C;Overweight     &#x7C;             $106.00&#x7C;$120.00             &#x7C;<br />
&#x7C;Vincent Andrews     &#x7C;Morgan Stanley      &#x7C;Lowers         &#x7C;Overweight     &#x7C;             $115.00&#x7C;$125.00             &#x7C;<br />
&#x7C;Jeffrey Zekaukas    &#x7C;JP Morgan           &#x7C;Lowers         &#x7C;Neutral        &#x7C;              $76.00&#x7C;$112.00             &#x7C;<br />
&#x7C;Aleksey Yefremov    &#x7C;Keybanc             &#x7C;Lowers         &#x7C;Overweight     &#x7C;             $120.00&#x7C;$128.00             &#x7C;<br />
&#x7C;Michael Sison       &#x7C;Wells Fargo         &#x7C;Lowers         &#x7C;Overweight     &#x7C;              $90.00&#x7C;$125.00             &#x7C;<br />
&#x7C;Joshua Spector      &#x7C;UBS                 &#x7C;Lowers         &#x7C;Buy            &#x7C;             $115.00&#x7C;$123.00             &#x7C;<br />
&#x7C;Charles Neivert     &#x7C;Piper Sandler       &#x7C;Lowers         &#x7C;Neutral        &#x7C;              $99.00&#x7C;$105.00             &#x7C;<br />
&#x7C;Patrick Cunningham  &#x7C;Citigroup           &#x7C;Lowers         &#x7C;Buy            &#x7C;             $101.00&#x7C;$105.00             &#x7C;<br />
&#x7C;John Roberts        &#x7C;Mizuho              &#x7C;Maintains      &#x7C;Outperform     &#x7C;             $105.00&#x7C;$105.00             &#x7C;<br />
&#x7C;Charles Neivert     &#x7C;Piper Sandler       &#x7C;Raises         &#x7C;Neutral        &#x7C;             $105.00&#x7C;$102.00             &#x7C;<br />
&#x7C;Arun Viswanathan    &#x7C;RBC Capital         &#x7C;Raises         &#x7C;Sector Perform &#x7C;             $103.00&#x7C;$101.00             &#x7C;<br />
&#x7C;Jeffrey Zekaukas    &#x7C;JP Morgan           &#x7C;Raises         &#x7C;Overweight     &#x7C;             $112.00&#x7C;$110.00             &#x7C;<br />
&#x7C;Michael Leithead    &#x7C;Barclays            &#x7C;Lowers         &#x7C;Equal-Weight   &#x7C;             $108.00&#x7C;$111.00             &#x7C;<br />
&#x7C;Aleksey Yefremov    &#x7C;Keybanc             &#x7C;Raises         &#x7C;Overweight     &#x7C;             $128.00&#x7C;$121.00             &#x7C;<br />
&#x7C;Joshua Spector      &#x7C;UBS                 &#x7C;Lowers         &#x7C;Buy            &#x7C;             $123.00&#x7C;$124.00             &#x7C;</p>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Eastman Chemical. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Eastman Chemical compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Eastman Chemical's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Eastman Chemical's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/EMN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Eastman Chemical analyst ratings.</strong></a></p>
<h2>All You Need to Know About Eastman Chemical</h2>
<p>Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.</p>
<h3>Financial Insights: Eastman Chemical</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Challenges:</strong> Eastman Chemical's revenue growth over 3M faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately <strong>-0.87%</strong>. This indicates a decrease in top-line earnings. When compared to others in the Materials sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Eastman Chemical's net margin is impressive, surpassing industry averages. With a net margin of <strong>7.95%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Eastman Chemical's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>3.12%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>1.21%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Eastman Chemical's debt-to-equity ratio is below the industry average at <strong>0.86</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Beyond The Numbers: 17 Analysts Discuss Eastman Chemical Stock

<p><strong>AZZ's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZZ#NYSE">AZZ</a>) short percent of float has risen 5.79% since its last report. The company recently reported that it has <strong>812 thousand shares sold short</strong>, which is 4.02% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 3.37 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>AZZ Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935228_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for AZZ has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing AZZ's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, AZZ's peer group average for short interest as a percentage of float is 4.81%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

What Does the Market Think About AZZ?

<p><strong>Masimo's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MASI#NYSE">MASI</a>) short percent of float has fallen 3.59% since its last report. The company recently reported that it has <strong>2.79 million shares sold short</strong>, which is 7.53% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 3.42 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>Masimo Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935223_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Masimo has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing Masimo's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Masimo's peer group average for short interest as a percentage of float is 4.06%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


MASI

Is the Market Bullish or Bearish on Masimo?

<p>During the last three months, 6 analysts shared their evaluations of Strategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $498.17, a high estimate of $619.00, and a low estimate of $409.00. A 5.92% drop is evident in the current average compared to the previous average price target of $529.50. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745935220_0.png" alt="price target chart" /></p>
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Strategy. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<p>&#x7C;      Analyst       &#x7C;     Analyst Firm      &#x7C; Action Taken  &#x7C;    Rating     &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C;<br />
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C;<br />
&#x7C;Mike Colonnese      &#x7C;HC Wainwright &amp; Co.    &#x7C;Announces      &#x7C;Buy            &#x7C;             $480.00&#x7C;-                   &#x7C;<br />
&#x7C;Ramsey El-Assal     &#x7C;Barclays               &#x7C;Lowers         &#x7C;Overweight     &#x7C;             $421.00&#x7C;$515.00             &#x7C;<br />
&#x7C;Bill Papanastasiou  &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Announces      &#x7C;Outperform     &#x7C;             $560.00&#x7C;-                   &#x7C;<br />
&#x7C;Matthew Galinko     &#x7C;Maxim Group            &#x7C;Raises         &#x7C;Buy            &#x7C;             $500.00&#x7C;$480.00             &#x7C;<br />
&#x7C;Brett Knoblauch     &#x7C;Cantor Fitzgerald      &#x7C;Raises         &#x7C;Overweight     &#x7C;             $619.00&#x7C;$613.00             &#x7C;<br />
&#x7C;Joseph Vafi         &#x7C;Canaccord Genuity      &#x7C;Lowers         &#x7C;Buy            &#x7C;             $409.00&#x7C;$510.00             &#x7C;</p>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Strategy. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Strategy compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Strategy's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Strategy's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/MSTR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Strategy analyst ratings.</strong></a></p>
<h2>Get to Know Strategy Better</h2>
<p>Strategy is a bitcoin treasury company and a provider of business intelligence services. It is designed to provide investors varying degrees of economic exposure to Bitcoin by offering a range of securities, including equity and fixed-income instruments. The company also provide industry AI-powered enterprise analytics software.</p>
<h3>Strategy: A Financial Overview</h3>
<p><strong>Market Capitalization:</strong> Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Strategy's financials over 3M reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately <strong>-3.04%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.</p>
<p><strong>Net Margin:</strong> Strategy's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>-555.78%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>-6.1%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Strategy's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>-3.92%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.4</strong>, Strategy adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Comments

Shell

Unusual Options Activity for

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Date	Put/Call	Strike Price	Exp Date	DTE	Trade Vol	Day Vol	Vol / OI	OI	Trade Type	Sentiment
03:44 PMMar 28, 2025	CALL	$70.00	Apr 17, 2025	-13	1513	1488	8	19023	SWEEP	BEARISH
10:22 AMMar 26, 2025	CALL	$75.00	Jan 16, 2026	261	2004	2000	74	2706	TRADE	BEARISH